semaglutide and optic neuritis A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Semaglutide Use Linked to Risk

References First GLP-1 tablet for weight loss approved in the UK , Medicines and Healthcare products Regulatory Agency, 2026 [Accessed 25 June 2026]

If TSH rises above your established range, your provider may increase levothyroxine slightly or adjust medication timing rather than discontinuing semaglutide

Yes, our partnering doctors can provide prescriptions based on the information you provide in the online questionnaires

Dysaesthesia (an abnormal skin sensation) affected around 21% of participants at the 12 mg dose

An Expert Doctor Weighs In with the Verdict GLP-1 patches for weight loss have made the scenebut a leading MD warns you they aren't the same as the more familiar prescriptions

How do you know if you have stomach paralysis from Ozempic